Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Announcement of Insurance Coverage for the Expanded Indication of Autologous Cultured Cartilage "JACC" for Knee Osteoarthritis
Japan Tissue Engineering, First Half Ordinary Profit Loss Widens, Jul-Sep Ordinary Profit Loss Widens
Summary of Financial Results for the second quarter 2026
Japan Tissue Engineering, Apr-Jun (1Q) Ordinary Profit Loss Widens
[Summary] Financial Results for the Three Months
[Delayed]Business Plan and Growth Potential
[Delayed]Financial Report for the Fiscal Year Ending March 2025
[Delayed]Non-consolidated Financial Results for the Fiscal Year Ended March 31, 2025
Japan Tissue Engineering Announces Approval for Expanded Indication of Autologous Cultured Cartilage "JACC" for Osteoarthritis
Japan Tissue Engineering, Returning to Profitability This Year
Summary of Financial Results for the third quarter 2025
Japan Tissue Engineering, The Current Fiscal Year Ordinary Profit Revised Downward to a Loss
Sysmex and J-TEC Sign a Basic Agreement to Advance Manufacturing Capabilities for Regenerative Medicine and Cell Therapy
Summary of Financial Results for the second quarter 2025
Japan Tissue Engineering Co., Ltd., July-September (2Q) Ordinary Profit Loss Narrows
Announcement of NHI Listing of Autologous Cultured Epidermis Maintaining Melanocytes "JACEMIN" for the Treatment of Vitiligo
Announcement on the Progress of the Clinical Trial of Allogeneic Cultured Epidermis Allo-JaCE03